A Multicenter, Prospective, Observational, Post Marketing Surveillance Study to Evaluate the Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Patients With Chronic Hepatitis C Virus Infection in India
Phase of Trial: Phase IV
Latest Information Update: 22 May 2018
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- Sponsors Gilead Sciences
- 14 May 2018 Status changed from active, no longer recruiting to completed.
- 06 Apr 2018 Planned End Date changed from 1 Mar 2018 to 1 May 2018.
- 16 Jan 2018 Planned End Date changed from 1 Apr 2018 to 1 Mar 2018.